TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2739680

Group type: EXPERIMENTAL
Intervention: Test cigarette (tobacco-heating); smokers
Number of subjects: 72

Group type: COMPARATOR
Intervention: Reference cigarette (tobacco-burning); smokers
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 72
Study: 31816425

Group type: EXPERIMENTAL
Intervention: Chair elastic-band muscle strength exercises (CSE), n = 20, 45 min, 3 times/week for 28 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chair-multimodal exercise (CME), n = 21, 45 min, 3 times/week for 28 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control non-exercise group (CGne), n = 19
Number of subjects: 60
Study: 31542128

Group type: EXPERIMENTAL
Intervention: Mobile app providing educational resources, goal setting, self-monitoring, and feedback strategies for 12 weeks
Number of subjects: 160
Study: 28719039

Group type: EXPERIMENTAL
Intervention: Oral steroid therapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection (IT)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Low-frequency group
Number of subjects: 111

Group type: COMPARATOR
Intervention: High-frequency group
Number of subjects: 111
Study: 25101909

Group type: COMPARATOR
Intervention: Conventional brackets (group 1, n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-ligating brackets (group 2, n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (group 3, n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 60
Study: 23811639

Group type: EXPERIMENTAL
Intervention: Preflared group (initial instrumentation with preflaring)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nonpreflared group (initial instrumentation without preflaring)
Number of subjects: 90
Study: 21232112

Group type: EXPERIMENTAL
Intervention: Land-based exercise group
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Water-based exercise group
Number of subjects: 618

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 618
Study: 19900236

Group type: EXPERIMENTAL
Intervention: Pioglitazone (force-titrated to 45 mg/day, n = 654)
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Placebo (n = 660)
Number of subjects: 1314
Study: 15758560

Group type: EXPERIMENTAL
Intervention: Oral glucose (100 g) administered at -30 min followed by TRH (200 microg iv) at 0 min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isoproterenol (0.012 microg/kg, iv) infused continuously with TRH (200 microg iv) at 0 min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oral glucose (100 g) at -30 min and isoproterenol infused continuously with TRH (200 microg iv) at 0 min
Number of subjects: 7

Group type: COMPARATOR
Intervention: TRH (200 microg iv) at 0 min without glucose or isoproterenol
Number of subjects: 7
Study: 12192476

Group type: EXPERIMENTAL
Intervention: Collection of fetal blood before delivery of the placenta
Number of subjects: 0

Group type: COMPARATOR
Intervention: Collection of fetal blood after delivery of the placenta
Number of subjects: 0
Study: 9794346

Group type: EXPERIMENTAL
Intervention: 25 mg carvedilol twice daily
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 50 mg carvedilol twice daily
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 12.5 mg carvedilol twice daily
Number of subjects: 122
Study: 7613927

Group type: EXPERIMENTAL
Intervention: J colonic pouch-anal anastomosis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Straight coloanal anastomosis
Number of subjects: 40
Study: 1978474

Group type: EXPERIMENTAL
Intervention: Remoxipride (150-600 mg daily for 6 weeks)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Haloperidol (5-20 mg daily for 6 weeks)
Number of subjects: 98
Study: 735716

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study: 30627833

Group type: COMPARATOR
Intervention: Unsupported worked examples
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Closed prompts (multiple-choice tasks)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Open reflection prompts
Number of subjects: 3
Study: 28497943

Group type: EXPERIMENTAL
Intervention: OTC self-adapted jaw-repositioning mouthguard (SA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: OTC custom-fitted jaw-repositioning mouthguard (CF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Placebo mouthguard (PLA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No mouthguard control (CON)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All conditions (CON, PLA, SA, CF)
Number of subjects: 20
Study: 24819823

Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cowhage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Female subjects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Male subjects
Number of subjects: 30
Study: 23921778

Group type: EXPERIMENTAL
Intervention: Primary care-based weight loss intervention
Number of subjects: 0
Study: 21809337

Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning (IPC) - 10 min inflow occlusion followed by 10 min reperfusion
Number of subjects: 84

Group type: COMPARATOR
Intervention: No IPC (Control group)
Number of subjects: 84
Study: 19282347

Group type: EXPERIMENTAL
Intervention: Linear treadmill protocol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bruce protocol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cycle ergometry
Number of subjects: 16
Study: 17333340

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg
Number of subjects: 907

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg
Number of subjects: 907
Study: 15155391

Group type: COMPARATOR
Intervention: Diet eliminating artificial colourings and benzoate preservatives for one week followed by a three week double blind crossover study with a drink containing artificial colourings (20 mg daily) and sodium benzoate (45 mg daily) during active periods.
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo mixture during the placebo period.
Number of subjects: 277
Study: 11549686

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 0.3 mg/kg/week
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no GH)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis subgroup
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis subgroups
Number of subjects: 19
Study: 9039927

Group type: EXPERIMENTAL
Intervention: CsA alone (group 1)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CsA plus steroids (group 2)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CsA plus steroids plus azathioprine (group 3)
Number of subjects: 53
Study: 7895587

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (leucomax) with chemotherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (only chemotherapy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (leucomax)
Number of subjects: 21
Study: 3285117

Group type: EXPERIMENTAL
Intervention: 60 or 85 g fructose
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sweet placebo
Number of subjects: 12
Study: 29884082

Group type: EXPERIMENTAL
Intervention: Oral paracetamol premedication
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 26965503

Group type: EXPERIMENTAL
Intervention: 80-kV protocol A (PA; 0.75 g iodine/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 80-kV protocol B (PB; 1 g iodine/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 120-kV standard protocol (PS; 0.75 g iodine/kg)
Number of subjects: 30
Study: 23873632

Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb)
Number of subjects: 2363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2363
Study: 23981616

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus of tirofiban (10 µg/kg)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Intracoronary bolus of urokinase (250 kU/20 ml)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus of tirofiban
Number of subjects: 490
Study: 20836720

Group type: EXPERIMENTAL
Intervention: Transvesical obturator nerve block (ONB) with spinal anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spinal anesthesia only (Control)
Number of subjects: 60
Study: 17960366

Group type: EXPERIMENTAL
Intervention: Nicotinized cigarette (NIC+)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Denicotinized cigarette (NIC‐)
Number of subjects: 165
Study: 15842075

Group type: EXPERIMENTAL
Intervention: Listening to Vivaldi's Four Seasons
Number of subjects: 0

Group type: COMPARATOR
Intervention: No music
Number of subjects: 0
Study: 12005359

Group type: EXPERIMENTAL
Intervention: Fiduxosin 30 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fiduxosin 60 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fiduxosin 90 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fiduxosin 120 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10065062

Group type: COMPARATOR
Intervention: Written materials only
Number of subjects: 191

Group type: COMPARATOR
Intervention: Written materials and videotape
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Written materials and small-group sessions facilitated by fourth-year medical students
Number of subjects: 191

Group type: COMPARATOR
Intervention: All three methods
Number of subjects: 191
Study: 7751411

Group type: EXPERIMENTAL
Intervention: Intravenous flucloxacillin (500 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oral flucloxacillin (500 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison with young healthy subjects
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Flucloxacillin renal clearance (Clr) regression on estimated creatine clearance (CLcr)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Total clearance, renal clearance, and volume of distribution
Number of subjects: 7
Study: 2268141

Group type: EXPERIMENTAL
Intervention: Insulin (0.1 U/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline administration
Number of subjects: 15
Study: 263132

Group type: EXPERIMENTAL
Intervention: Barium enema studies
Number of subjects: 73
Study: 30669509

Group type: EXPERIMENTAL
Intervention: Psyllium
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 24
Study: 29252175

Group type: EXPERIMENTAL
Intervention: Topical capsaicin solution
Number of subjects: 27

Group type: COMPARATOR
Intervention: Immersion oil (Control group)
Number of subjects: 27
Study: 25675380

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg bid) for 6 months
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 178
Study: 23307540

Group type: EXPERIMENTAL
Intervention: Pharmacy case manager recommendations accepted by inpatient physicians
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to updating the record after medication reconciliation
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to actual allergies
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to medication errors
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to drug indications
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to drug efficacy
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations related to therapeutic drug and disease state monitoring
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Recommendations for patients with a greater number of drugs
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Overall impact on health care use 90 days after discharge
Number of subjects: 192
Study: 21283552

Group type: EXPERIMENTAL
Intervention: 1% tenofovir gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study: 20003839

Group type: EXPERIMENTAL
Intervention: Creatine (2x3 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin (2x500 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Basal glucose values)
Number of subjects: 0
Study: 17241504

Group type: EXPERIMENTAL
Intervention: BIS 50 group (bispectral index 45-55)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: BIS 40 group (bispectral index 35-44)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 15019868

Group type: EXPERIMENTAL
Intervention: Clopidogrel pretreatment
Number of subjects: 79
Study: 11712936

Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 371

Group type: COMPARATOR
Intervention: Breastfeeding
Number of subjects: 371
Study: 10921701

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (loading dose of 150 mg and maintenance dose of 0.4 mg x kg(‐1) x h(‐1) for 3 days before and 5 days after operation)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (matching infusions of 5% glucose solution)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study: 8748411

Group type: EXPERIMENTAL
Intervention: Eurocollins plus nicardipine
Number of subjects: 127

Group type: COMPARATOR
Intervention: Eurocollins
Number of subjects: 127
Study: 1433585

Group type: EXPERIMENTAL
Intervention: Medical management (continuous low dose antibiotic prophylaxis until vesicoureteral reflux resolved)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Surgical management (type of procedure at surgeon's discretion)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 132

Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 132
Study: 2865943

Group type: EXPERIMENTAL
Intervention: Early vitrectomy
Number of subjects: 616

Group type: COMPARATOR
Intervention: Deferral of vitrectomy
Number of subjects: 616
Study: 30540257

Group type: EXPERIMENTAL
Intervention: 100ms delay group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1000ms delay group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First type of near-miss configuration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second type of near-miss configuration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delay time
Number of subjects: 0
Study: 26280707

Group type: EXPERIMENTAL
Intervention: 3 cm pancreatic stent
Number of subjects: 240

Group type: COMPARATOR
Intervention: 5 cm pancreatic stent
Number of subjects: 240
Study: 24651160

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with virgin olive oil
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Mediterranean diet groups (olive oil and nuts)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 424
Study: 22457391

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern (DP)
Number of subjects: 0
Study: 20117687

Group type: EXPERIMENTAL
Intervention: Anger management program for family members of patients with AUDs
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 63
Study: 18060898

Group type: EXPERIMENTAL
Intervention: Psychosocial fruit and vegetable evaluation tool
Number of subjects: 93
Study: 16254743

Group type: EXPERIMENTAL
Intervention: Family representative payeeship
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Family contact
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Substance abuse
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: History of violence
Number of subjects: 245
Study: 11953190

Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine (TMPZ) 4 mg/kg injected intravenously before blood collection and added to washing fluid.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tetramethylpyrazine (TMPZ) 4 mg/kg injected intravenously before blood collection, but not added to washing fluid.
Number of subjects: 60
Study: 10190648

Group type: EXPERIMENTAL
Intervention: Tolterodine 4 mg L-tartrate orally twice daily for 6 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Debrisoquine and caffeine
Number of subjects: 12
Study: 7585998

Group type: EXPERIMENTAL
Intervention: Mid-laser therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 0
Study: 1977411

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 13
Study: 31155160

Group type: EXPERIMENTAL
Intervention: Tunneled PICCs (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal PICCs (control group)
Number of subjects: 60
Study: 28993042

Group type: EXPERIMENTAL
Intervention: Sacroiliac joint manipulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 32
Study: 27161966

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (10 mg/m²/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24561814

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) - 4-6 × 30 s of all-out cycling efforts with 4-min recovery, 6 sessions within 2 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Aerobic Endurance Training (AET) - 40-60 min at 60% of peak workload, 6 sessions within 2 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) - 6 sessions within 2 weeks
Number of subjects: 26
Study: 22330085

Group type: EXPERIMENTAL
Intervention: IFN‐γ treatment
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 100 U IFN‐γ in vitro
Number of subjects: 19

Group type: COMPARATOR
Intervention: TMP‐SMX treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 19
Study: 21388056

Group type: EXPERIMENTAL
Intervention: Hypofractionated 3-dimensional conformal radiotherapy (72 Gy in 30 fractions)
Number of subjects: 25
Study: 17942817

Group type: EXPERIMENTAL
Intervention: Albuterol (12 mg per day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 16786743

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no immunotherapy)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Acoustic rhinometry
Number of subjects: 22
Study: 12598278

Group type: EXPERIMENTAL
Intervention: 3 mL of 1% lidocaine
Number of subjects: 65

Group type: COMPARATOR
Intervention: 1 mL of 3% lidocaine
Number of subjects: 65
Study: 10375923

Group type: EXPERIMENTAL
Intervention: Colposcopy in patients with ASCUS
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group with unsuspected cytology findings
Number of subjects: 73
Study: 9049963

Group type: EXPERIMENTAL
Intervention: Grade I acute GVHD
Number of subjects: 2902

Group type: EXPERIMENTAL
Intervention: Grades II, III, IV acute GVHD
Number of subjects: 2902

Group type: COMPARATOR
Intervention: No acute GVHD
Number of subjects: 2902

Group type: EXPERIMENTAL
Intervention: Grades I-IV acute GVHD
Number of subjects: 2902

Group type: EXPERIMENTAL
Intervention: Grades 0, I, II, III, IV acute GVHD
Number of subjects: 2902
Study: 1996932

Group type: EXPERIMENTAL
Intervention: Incremental exposure (two 4-min pre-exposure periods at 15 degrees/s and 30 degrees/s) followed by 16-min exposure at 60 degrees/s
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (standard 16-min exposure at 60 degrees/s with no pre-exposure)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Abrupt exposure (two 4-min pre-exposure periods at 60 degrees/s) followed by 16-min exposure at 60 degrees/s
Number of subjects: 45
Study: 6662177

Group type: EXPERIMENTAL
Intervention: Piretanide 3 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Piretanide 12 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31796532

Group type: EXPERIMENTAL
Intervention: Exercise and nutrition program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 30797255

Group type: EXPERIMENTAL
Intervention: Stannous fluoride toothpaste
Number of subjects: 129

Group type: COMPARATOR
Intervention: Sodium monofluorophosphate dentifrice
Number of subjects: 129
Study: 29503163

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 2413

Group type: EXPERIMENTAL
Intervention: General antipsychotic treatment response
Number of subjects: 2413
Study: 26112815

Group type: COMPARATOR
Intervention: Windsurfers (N=8)
Number of subjects: 8
Study: 25111080

Group type: EXPERIMENTAL
Intervention: Standard dose ATG (sATG) 3.75 mg/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lower dose ATG (lowATG) 2.25 mg/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: sATG
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: lowATG
Number of subjects: 45
Study: 22339146

Group type: EXPERIMENTAL
Intervention: Adapted eight-module HIV prevention program
Number of subjects: 812

Group type: COMPARATOR
Intervention: General health curriculum
Number of subjects: 812
Study: 19577217

Group type: EXPERIMENTAL
Intervention: Stress radionuclide myocardial perfusion imaging (MPI)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 400
Study: 17195144

Group type: EXPERIMENTAL
Intervention: Severing the umbilical cord after delivery of the anterior shoulder
Number of subjects: 60

Group type: COMPARATOR
Intervention: Leaving the umbilical cord intact
Number of subjects: 60
Study: 14872017

Group type: EXPERIMENTAL
Intervention: Clozapine (39.4 ± 4.5 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 50
Study: 12487830

Group type: EXPERIMENTAL
Intervention: NaCl 0.9% infusion with 1 IU of heparin per milliliter
Number of subjects: 300

Group type: COMPARATOR
Intervention: NaCl 0.9% infusion (control)
Number of subjects: 300